Trials / Completed
CompletedNCT06871280
Assessment of Vertigo and Dizziness in Individuals Following COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 296 (actual)
- Sponsor
- Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Other Government
- Sex
- All
- Age
- 20 Years – 66 Years
- Healthy volunteers
- —
Summary
This cross-sectional study aimed to assess the prevalence of dizziness/vertigo in individuals following COVID-19 and to investigate potential risk factors associated with these symptoms. A total of 296 patients aged 20-66 years who had recovered from COVID-19 were evaluated at Istanbul Physical Medicine and Rehabilitation Training and Research Hospital between June 1, 2021, and December 31, 2021. Clinical and demographic data, including COVID-19 history, comorbidities, and symptom characteristics, were collected. Dizziness-related disability was assessed using the Dizziness Handicap Inventory (DHI), while balance performance was evaluated with the Berg Balance Scale (BBS).
Conditions
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2025-03-11
- Last updated
- 2025-03-11
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06871280. Inclusion in this directory is not an endorsement.